The effect of vitamin D supplementation on hypertension in non-CKD populations: A systemic review and meta-analysis

International Journal of Cardiology

Volumn 227, Issue , 2017, Pages 177-186

  Qi, Dan ^a   Nie, Xiaolu ^a   Cai, Jun ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Hypertension; Meta analysis; Systemic review; Vitamin D

Indexed keywords

ALFACALCIDOL; COLECALCIFEROL; PLACEBO; VITAMIN D;

DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; VITAMIN SUPPLEMENTATION; BLOOD PRESSURE; DIETARY SUPPLEMENT; DRUG EFFECTS; FEMALE; MALE; SENSITIVITY AND SPECIFICITY;

BLOOD PRESSURE; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HYPERTENSION; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY; VITAMIN D;

EID: 84997079004     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.11.040     Document Type: Review

References (45)

1. [1] Holick, M.F., Vitamin D deficiency. N. Engl. J. Med. 357:3 (2007), 266–281.
2. [2] Holick, M.F., Chen, T.C., Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr. 87:4 (2008), 1080s–1086s.
3. [3] Liu, L., Chen, M., Hankins, S.R., et al. Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality from all-cause in United States adults. Am. J. Cardiol. 110:6 (2012), 834–839.
4. [4] Zittermann, A., Iodice, S., Pilz, S., et al. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 95:1 (2012), 91–100.
5. [5] Wang, L., Song, Y., Manson, J.E., et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes 5:6 (2012), 819–829.
6. [6] Burgaz, A., Orsini, N., Larsson, S.C., Wolk, A., Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J. Hypertens. 29:4 (2011), 636–645.
7. [7] Forman, J.P., Giovannucci, E., Holmes, M.D., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49:5 (2007), 1063–1069.
8. [8] Wang, T.J., Pencina, M.J., Booth, S.L., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:4 (2008), 503–511.
9. [9] Forman, J.P., Curhan, G.C., Taylor, E.N., Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 52:5 (2008), 828–832.
10. [10] Judd, S.E., Nanes, M.S., Ziegler, T.R., Wilson, P.W., Tangpricha, V., Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the Third National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 87:1 (2008), 136–141.
11. [11] Scragg, R., Sowers, M., Bell, C., Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am. J. Hypertens. 20:7 (2007), 713–719.
12. [12] Sypniewska, G., Pollak, J., Strozecki, P., et al. 25-hydroxyvitamin D, biomarkers of endothelial dysfunction and subclinical organ damage in adults with hypertension. Am. J. Hypertens. 27:1 (2014), 114–121.
13. [13] Henry, H.L., Bouillon, R., Norman, A.W., et al. 14th Vitamin D Workshop consensus on vitamin D nutritional guidelines. J. Steroid Biochem. Mol. Biol. 121:1–2 (2010), 4–6.
14. [14] Pludowski, P., Holick, M.F., Pilz, S., et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun. Rev. 12:10 (2013), 976–989.
15. [15] Li, Y.C., Vitamin D regulation of the renin–angiotensin system. J. Cell. Biochem. 88:2 (2003), 327–331.
16. [16] Tare, M., Emmett, S.J., Coleman, H.A., et al. Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats. J. Physiol. 589:Pt 19 (2011), 4777–4786.
17. [17] Wong, M.S., Delansorne, R., Man, R.Y., Svenningsen, P., Vanhoutte, P.M., Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am. J. Physiol. Heart Circ. Physiol. 299:4 (2010), H1226–H1234.
18. [18] Weng, S., Sprague, J.E., Oh, J., et al. Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice. PLoS One, 8(1), 2013, e54625.
19. [19] Wang, L., Ma, J., Manson, J.E., et al. A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men. Eur. J. Nutr. 52:7 (2013), 1771–1779.
20. [20] Griffin, F.C., Gadegbeku, C.A., Sowers, M.R., Vitamin D and subsequent systolic hypertension among women. Am. J. Hypertens. 24:3 (2011), 316–321.
21. [21] Anderson, J.L., May, H.T., Horne, B.D., et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106:7 (2010), 963–968.
22. [22] Jorde, R., Figenschau, Y., Emaus, N., Hutchinson, M., Grimnes, G., Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension 55:3 (2010), 792–798.
23. [23] Margolis, K.L., Ray, R.M., Van Horn, L., et al. Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial. Hypertension 52:5 (2008), 847–855.
24. [24] Forman, J.P., Scott, J.B., Ng, K., et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 61:4 (2013), 779–785.
25. [25] Witham, M.D., Ireland, S., Houston, J.G., et al. Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial. Hypertension 63:4 (2014), 706–712.
26. [26] Witham, M.D., Adams, F., Kabir, G., et al. Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK—a randomised controlled trial. Atherosclerosis 230:2 (2013), 293–299.
27. [27] Witham, M.D., Dove, F.J., Sugden, J.A., Doney, A.S., Struthers, A.D., The effect of vitamin D replacement on markers of vascular health in stroke patients—a randomised controlled trial. Nutr. Metab. Cardiovasc. Dis. 22:10 (2012), 864–870.
28. [28] Scragg, R., Slow, S., Stewart, A.W., et al. Long-term high-dose vitamin D3 supplementation and blood pressure in healthy adults: a randomized controlled trial. Hypertension 64:4 (2014), 725–730.
29. [29] Moghassemi, S., Marjani, A., The effect of short-term vitamin D supplementation on lipid profile and blood pressure in post-menopausal women: a randomized controlled trial. Iran J. Nurs. Midwifery Res. 19:5 (2014), 517–521.
30. [30] Lind, L., Pollare, T., Hvarfner, A., et al. Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. Diabetes Res. 11:3 (1989), 141–147.
31. [31] Larsen, T., Mose, F.H., Bech, J.N., Hansen, A.B., Pedersen, E.B., Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am. J. Hypertens. 25:11 (2012), 1215–1222.
32. [32] Jorde, R., Sneve, M., Torjesen, P., Figenschau, Y., No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J. Intern. Med. 267:5 (2010), 462–472 include no HBP.
33. [33] Daly, R.M., Nowson, C.A., Long-term effect of calcium-vitamin D(3) fortified milk on blood pressure and serum lipid concentrations in healthy older men. Eur. J. Clin. Nutr. 63:8 (2009), 993–1000.
34. [34] Jorde, R., Sneve, M., Torjesen, P., Figenschau, Y., No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J. Intern. Med. 267:5 (2010), 462–472.
35. [35] Wu, S.H., Ho, S.C., Zhong, L., Effects of vitamin D supplementation on blood pressure. South. Med. J. 103:8 (2010), 729–737.
36. [36] Kunutsor, S.K., Burgess, S., Munroe, P.B., Khan, H., Vitamin D and high blood pressure: causal association or epiphenomenon?. Eur. J. Epidemiol. 29:1 (2014), 1–14.
37. [37] Beveridge, L.A., Struthers, A.D., Khan, F., et al. Effect of vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data. JAMA Intern. Med. 175:5 (2015), 745–754.
38. [38] Vaidya, A., Williams, J.S., The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metabolism 61:4 (2012), 450–458.
39. [39] Entezari, M.H., The effect of supplementary calcium on blood pressure in healthy adult women aged 18-30 years in Tehran. Iran. J. Educ. Health Promot., 4, 2015, 67.
40. [40] Bristow, S.M., Gamble, G.D., Stewart, A., Horne, A.M., Reid, I.R., Acute effects of calcium supplements on blood pressure and blood coagulation: secondary analysis of a randomised controlled trial in post-menopausal women. Br. J. Nutr., 1–7, 2015.
41. [41] Bolland, M.J., Barber, P.A., Doughty, R.N., et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336:7638 (2008), 262–266.
42. [42] Shab-Bidar, S., Bours, S., Geusens, P.P., Kessels, A.G., van den Bergh, J.P., Serum 25(OH)D response to vitamin D3 supplementation: a meta-regression analysis. Nutrition 30:9 (2014), 975–985.
43. [43] Arora, P., Song, Y., Dusek, J., et al. Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation 131:3 (2015), 254–262.
44. [44] Abbasi, F., Feldman, D., Caulfield, M.P., Hantash, F.M., Reaven, G.M., Relationship among 25-hydroxyvitamin D concentrations, insulin action, and cardiovascular disease risk in patients with essential hypertension. Am. J. Hypertens. 28:2 (2015), 266–272.
45. [45] Dhaliwal, R., Mikhail, M., Feuerman, M., Aloia, J.F., The vitamin D dose response in obesity. Endocr. Pract. 20:12 (2014), 1258–1264.